Drugs / Influenza HA vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02555618 Comparator | Sep → Dec 2015 | influenza | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza HA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02555618 ↗ |
| Modality | Vaccine | “influenza HA vaccine” NCT02555618 ↗ |
| Route | Subcutaneous | “influenza HA vaccine subcutaneous injection” NCT02555618 ↗ |